Results 171 to 180 of about 21,301 (244)

Extent of Embolization as an Independent Prognostic Factor in Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Okumura K, Ogi T, Matsumoto J, Asato N, Kitao A, Kobayashi S, Kozaka K.   +6 more
europepmc   +1 more source

Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma. [PDF]

Medicine (Baltimore)
Yang J, Xu Q, Wu S.
europepmc   +1 more source

Efficacy and safety of tyrosine kinase inhibitors combined with sintilimab and transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma: a pooled analysis. [PDF]

J Gastrointest Oncol
Lu GL, Tu JM, Hussainzai A, Tong F, Jiang R.   +4 more
europepmc   +1 more source

Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics. [PDF]

J Hepatocell Carcinoma
Hassan M, Hussain I, Ahmad K, Zafar S, Khalid A, Haseeb M, Hussain N, Ghafar MA.   +7 more
europepmc   +1 more source

Efficacy and Safety of Stereotactic Body Radiation Therapy Modalities for >5 cm Advanced Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis. [PDF]

Cancers (Basel)
Leung HWC, Wang SY, Leung JH, Tai YS, Chan ALF.   +4 more
europepmc   +1 more source

Early Recurrent Hepatocellular Carcinoma with CK19 Positive Receiving Transarterial Chemoembolization After Surgical Resection: A Novel Risk Model Study. [PDF]

J Hepatocell Carcinoma
Zhu D, Yang W, Zhou HF, Liu S, Zhou WZ, Shao ZF, Shi HB, Feng Q.   +7 more
europepmc   +1 more source

Transcatheter arterial chemoembolization of liver tumors: Effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency [PDF]

, 2003
Choti, M.A., Cleffken, B.I. (Berry), Geschwind, H., Hartnell, G.G. (George), Juluru, K. (Krishna), Kobeiter, H. (Hicham), Ramsey, D.E. (Douglas), Wal, B.C.H. (Bart C.) van der   +7 more
core   +1 more source

Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Cohort Study. [PDF]

Cancer Med
Taniki N, Ojiro K, Kasuga R, Nakadai Y, Tabuchi T, Chu PS, Usui S, Hoshi H, Kaneko F, Yamaguchi A, Koizumi J, Ebinuma H, Tamura M, Tsukada J, Inoue M, Nakatsuka S, Hasegawa Y, Abe Y, Kitago M, Jinzaki M, Kitagawa Y, Kanai T, Nakamoto N.   +22 more
europepmc   +1 more source

Development of a Research Agenda for the Management of Metastatic Colorectal Cancer: Proceedings from a Multidisciplinary Research Consensus Panel [PDF]

, 2012
Cohen, Steven J., d’Othée, Bertrand Janne, Geschwind, Jean-Francois, Hanna, Nader, Johnson, Matthew S., Kee, Stephen T., Kennedy, Andrew S., Lewandowski, Robert J., Murthy, Ravi, Sofocleous, Constantinos T., Soulen, Michael C., Vauthey, Jean-Nicolas, Venook, Alan P.   +12 more
core   +1 more source

Inflammation-tumor burden interaction score stratifies survival after irinotecan-eluting bead chemoembolization for colorectal liver metastases. [PDF]

Front Med (Lausanne)
Doğan T, Taş S, Hafızoğlu E, Güçlü Kantar T, Çakan Demirel B, İspir E, Çomut E, Arslan M, Yapar Taşköylü B, Gökçen Demiray A, Yaren A, Gököz Doğu G.   +11 more
europepmc   +1 more source